[In vitro study on the influence of fibrin in cartilage constructs based on PGA fleece materials].
BACKGROUND
The matrix component in autologous chondrocyte implantation plays an important role. In this study the influence of an additional fibrin component in cartilage constructs based on polyglycolide polymers (PGA) was investigated.


METHODS
Human chondrocytes of femoral heads were isolated and cultured using a serum-free technique. The cells were seeded on PGA-91 scaffolds with and without an additional fibrin component; the constructs were cultured for 2 weeks in vitro. Besides cell viability, DNA content, pH, aggrecan production, mRNA expression of aggrecan, and collagen types I and II were determined by real-time PCR. Furthermore, cartilage grafts were histologically analyzed.


RESULTS
All constructs contained viable, metabolically active cells in the investigated time period. There was no cell proliferation within the graft, and the DNA content was decreased over time. The pH level constantly remained within a physiologic range. The Alcian blue staining of the constructs showed the homogeneous cell distribution and a cell-associated proteoglycan production. Aggrecan concentration in the supernatants of fibrin-containing constructs was significantly lower compared to fibrin-free grafts (-24%), a result that correlated with diminished aggrecan mRNA expression (-80%). mRNA expression of collagen type II increased in the fibrin-free constructs over time and was 57% higher than in the fibrin-containing grafts. The immunohistochemical detection of collagen type II was possible in all constructs.


CONCLUSIONS
Cartilage constructs based on carbohydrate matrices are suitable for matrix-associated chondrocyte implantation. The results of this study suggest a partially inhibitory effect of an additional fibrin component in PGA constructs for chondrogenic differentiation.
Schmal
H
H
Department für Orthopädie und Traumatologie, Universitätsklinik Freiburg, Hugstetter Strasse 55, 79106 Freiburg im Breisgau. hagen.schmal@freenet.de
Mehlhorn
A T
AT
Kurze
C
C
Zwingmann
J
J
Niemeyer
P
P
Finkenzeller
G
G
Dauner
M
M
Südkamp
N P
NP
Köstler
W
W
D018929:Cell Culture Techniques / Q000379:methods*; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology* / Q000502:physiology*; D020219:Chondrogenesis / Q000187:drug effects / Q000502:physiology*; D005337:Fibrin / Q000008:administration & dosage / Q000737:chemistry*; D006801:Humans; D011099:Polyglutamic Acid / Q000737:chemistry*; D023822:Tissue Engineering / Q000379:methods*
D011099:Polyglutamic Acid; D005337:Fibrin